[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100200817":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":16,"responsibleParty":37,"collaborators":7,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":7,"eligibilityCriteria":45,"healthyVolunteers":41,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":52,"studyType":53,"phases":7,"briefSummary":54,"conditions":55,"keywords":7,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Wake Forest University Health Sciences","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Dianna Howard, MD","PRINCIPAL_INVESTIGATOR",[13],{"name":10,"role":14,"phone":7,"phoneExt":7,"email":15},"CONTACT","dhoward@wakehealth.edu",[17],{"facility":18,"status":19,"city":20,"state":21,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Wake Forest Baptist Health","RECRUITING","Winston-Salem","North Carolina","27157","United States","US",{"type":26,"coordinates":27},"Point",[28,29],-80.24422,36.09986,{"lat":29,"lon":28},[32,36],{"name":33,"role":14,"phone":34,"phoneExt":7,"email":35},"David Hurd, MD","336-716-2843","dhurd@wakehealth.edu",{"name":33,"role":11,"phone":7,"phoneExt":7,"email":7},{"type":38,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100200817","the-prospective-collection-storage-and-reporting-of-data-on-patients-undergoing-hematopoietic-stem-cell-transplantation-utilizing-a-standard-preparative-regimen-100200817",false,"NCT01890486","The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen","The Prospective Collection, Storage and Reporting of Data on Patients","Inclusion Criteria:\n\nPlanned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant\n\nExclusion Criteria:\n\nParticipation in any other treatment research protocol","ALL","18 Years","120 Years",{"count":50,"type":51},2000,"ESTIMATED","1 Year","OBSERVATIONAL","To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.",[56,57,58,59,60,61,62,63,64,65],"Acute Myelogenous Leukemia","Acute Lymphocytic Leukemia","Chronic Myelogenous Leukemia","Non-Hodgkin's Lymphoma","Hodgkin's Disease","Multiple Myeloma","Germ Cell Neoplasms","Myelodysplastic Syndromes","Chronic Lymphocytic Leukemia","Immunodeficiency Diseases","2026-04-09",{"date":68,"type":69},"2026-04-13","ACTUAL",{"date":71,"type":69},"2001-05-21",{"date":73,"type":51},"2026-12",{"name":5,"class":6},1]